Concepedia

Author

A.R. Bradwell

University of BirminghamORCID

Also Known As

A BRADWELL, A Bradwell, A R Bradwell, A. BRADWELL, A. Bradwell, A. R. BRADWELL, A. R. Bradwell, A.R Bradwell, A.R. BRADWELL, A.R. Bradwell

383

Publications

14.8K

Citations

60

H-Index

218

Concepts

All Affiliations

University of BirminghamQueen Elizabeth Hospital BirminghamMayo Clinic in ArizonaUniversity College LondonQueen Elizabeth Hospital
AB

About

A.R. Bradwell is an author at University of Birmingham specializing in medicine, pathology, and immunology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

36

70

5.2K

2

Health Sciences

11

14

587

3

Engineering

9

9

863

4

Education

1

1

11

5

Humanities

1

1

15

A.R. Bradwell

×

136

Publications

13.3K

Citations

56

H-Index

YearCitations

Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance

S. Vincent Rajkumar, Robert A. Kyle, Terry M. Therneau,

Blood

2005

690

Highly Sensitive, Automated Immunoassay for Immunoglobulin Free Light Chains in Serum and Urine

A.R. Bradwell, Hugh D Carr-Smith, Graham P. Mead,

Clinical Chemistry

2001

639

Serum reference intervals and diagnostic ranges for free kappa and free lambda immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains.

Jerry A. Katzmann, Raynell Clark, Roshini S. Abraham,

PubMed

2002

620

Serum Reference Intervals and Diagnostic Ranges for Free κ and Free λ Immunoglobulin Light Chains: Relative Sensitivity for Detection of Monoclonal Light Chains

Jerry A. Katzmann, Raynell Clark, Roshini S. Abraham,

Clinical Chemistry

2002

606

THE LAKE-LOUISE ACUTE MOUNTAIN-SICKNESS SCORING SYSTEM

Robert C. Roach, Peter Bärtsch, Peter H. Hackett,

1993

535

Outcome in systemic AL amyloidosis in relation to changes in concentration of circulating free immunoglobulin light chains following chemotherapy

Helen J. Lachmann, R Gallimore, Julian D. Gillmore,

British Journal of Haematology

2003

430

Serum free light-chain measurements for identifying and monitoring patients with nonsecretory multiple myeloma

Mark T. Drayson, Lian X. Tang, Roger Drew,

Blood

2001

419

ATM Mutations and Phenotypes in Ataxia-Telangiectasia Families in the British Isles: Expression of Mutant ATM and the Risk of Leukemia, Lymphoma, and Breast Cancer

Tatjana Stanković, A. Kidd, Amanda Sutcliffe,

The American Journal of Human Genetics

1998

399

Prevalence and risk of progression of light-chain monoclonal gammopathy of undetermined significance: a retrospective population-based cohort study

Angela Dispenzieri, Jerry A. Katzmann, Robert A. Kyle,

The Lancet

2010

383

Quantitative Assessment of Serum and Urinary Polyclonal Free Light Chains in Patients with Chronic Kidney Disease

Colin A. Hutchison, Stephen Harding, Pete Hewins,

Clinical Journal of the American Society of Nephrology

2008

358

Page 1